These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18525051)

  • 1. DNA methylation in lung cancer.
    Toyooka S; Matsuo K; Gazdar AF
    N Engl J Med; 2008 Jun; 358(23):2513; author reply 2514. PubMed ID: 18525051
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation.
    Tian L; Suzuki M; Nakajima T; Kubo R; Sekine Y; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I;
    Cancer; 2008 Sep; 113(6):1396-403. PubMed ID: 18666211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
    Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
    Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients.
    Tibaldi C; Giovannetti E; Vasile E; Boldrini L; Gallegos-Ruiz MI; Bernardini I; Incensati R; Danesi R; Cappuzzo F; Peters GJ; Fontanini G
    J Thorac Oncol; 2011 Feb; 6(2):395-6. PubMed ID: 21252721
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of combined detection of plasma RASSF1A and p16 gene methylation in diagnosis of non-small cell lung cancers].
    Liu GZ; Wu YM; Yang JY
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):613-4. PubMed ID: 18210883
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
    Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
    Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of hotspot mutations in epidermal growth factor receptor by polymerase chain reaction facilitates the management of non-small cell lung cancer.
    Hung KS; Lee CN; Liu HE
    J Thorac Oncol; 2008 Oct; 3(10):1202-3. PubMed ID: 18827621
    [No Abstract]   [Full Text] [Related]  

  • 8. Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer.
    Suzuki M; Shigematsu H; Nakajima T; Kubo R; Motohashi S; Sekine Y; Shibuya K; Iizasa T; Hiroshima K; Nakatani Y; Gazdar AF; Fujisawa T
    Clin Cancer Res; 2007 Oct; 13(20):6087-92. PubMed ID: 17947472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.
    Mohapatra PR; Punatar S; Prabhash K
    Eur Respir J; 2012 Jun; 39(6):1550-1; author reply 1551. PubMed ID: 22654017
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between aberrant methylation and survival in non-small-cell lung cancers.
    Toyooka S; Suzuki M; Maruyama R; Toyooka KO; Tsukuda K; Fukuyama Y; Iizasa T; Aoe M; Date H; Fujisawa T; Shimizu N; Gazdar AF
    Br J Cancer; 2004 Aug; 91(4):771-4. PubMed ID: 15266335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor mutations in non-small cell lung cancer: predicting clinical response to kinase inhibitors.
    Sequist LV; Haber DA; Lynch TJ
    Clin Cancer Res; 2005 Aug; 11(16):5668-70. PubMed ID: 16115901
    [No Abstract]   [Full Text] [Related]  

  • 12. Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.
    Schwab R; Pinter F; Moldavy J; Papay J; Strausz J; Kopper L; Keri G; Pap A; Petak I; Oreskovich K; Mangel L
    J Clin Oncol; 2005 Oct; 23(30):7736-8. PubMed ID: 16234532
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.
    Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.
    Cho D; Kocher O; Lee JC; Tenen DG; Meyerson ML; Janne PA; Halmos B
    J Clin Oncol; 2005 Jan; 23(1):235-7. PubMed ID: 15625379
    [No Abstract]   [Full Text] [Related]  

  • 15. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
    Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
    Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
    Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
    Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? Yes.
    Sterman DH
    Chest; 2013 Mar; 143(3):597-600. PubMed ID: 23460149
    [No Abstract]   [Full Text] [Related]  

  • 20. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
    Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
    Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.